ARTICLE | Company News
EU approves SkyePharma's DepoCyte
August 8, 2001 7:00 AM UTC
SkyePharma (LSE:SKP; SKYE) received EU marketing approval for DepoCyte cytarabine liposome injection for lymphomatous meningitis. The approval triggers a milestone payment to SKP from Elan (ELN), whic...